PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.6325
+0.0027 (0.43%)
May 20, 2025, 1:57 PM - Market open
PAVmed Employees
PAVmed had 39 employees as of December 31, 2024. The number of employees decreased by 68 or -63.55% compared to the previous year.
Employees
39
Change (1Y)
-68
Growth (1Y)
-63.55%
Revenue / Employee
$51,103
Profits / Employee
$1,857,667
Market Cap
19.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
PAVM News
- 5 days ago - PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 6 days ago - Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 19 days ago - PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025 - PRNewsWire
- 20 days ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - PRNewsWire
- 26 days ago - NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD - PRNewsWire
- 5 weeks ago - Lucid Diagnostics Announces Closing of Public Offering of Common Stock - PRNewsWire
- 5 weeks ago - Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - PRNewsWire